Use of Gas Chromatomass Spectroscopy for Analysis of Salicylate Contents in Plasma from Patients with Cerebrovascular Diseases Taking Aspirin as Antiaggregant Therapy

Colorimetric 3D microPAD for Multiplexed Detection of Paracetamol and Aspirin in Urine and Saliva

In this work, a novel 3D μPAD cellulose-based colorimetric chemosensor for multiplexed detection of paracetamol and aspirin in biological samples is proposed. The easy availability of analgesics such as paracetamol and non-steroidal anti-inflammatory drugs such as aspirin, over-the-counter drugs that can be acquired without medical prescription, can entail a health problem if they are administered incorrectly. The development of analytical procedures for the rapid, sensitive, and accurate determination of such drugs in clinical samples is of utmost importance. Different parameters involved in the design of the 3D μPAD system and the colorimetric reaction conditions have been optimized. Under optimal conditions, detection limits of 0.004 mM and 0.013 mM were obtained for paracetamol and aspirin, respectively. The proposed procedure was validated against two certified reference materials and applied to the analysis of several synthetic urine and saliva samples. Synthetic urine and saliva samples were spiked at two concentration levels, showing recoveries in the range of 98-103% with a relative standard deviation of 3-6% (n = 6).

Monitoring of salicylic acid content in human saliva and its relationship with plasma concentrations

Aspirin is a widely used anti-inflammatory drug. It is reported that a relationship may exist between salicylic acid content in plasma and saliva after taking aspirin. This study established a rapid, convenient, and safe method to assess salicylic acid concentration in human saliva. A novel HPLC-ultraviolet detector was used to measure salicylic acid concentrations in human saliva and plasma. A C18 reversed-phase column with an aqueous solution of 0.1% trifluoroacetic acid (TFA)-acetonitrile mobile phase was used, and drug peaks were recorded at 303 nm. Salicylic acid was completely separated in saliva and plasma. Excellent linearity and correlation (r² ≥ 0.9999) was observed between 0.1 and 2.0 μg/mL. The detection limit (S/N = 3) was 33 ng/mL, and intra- and inter-day recoveries were 103.5-113.3% and 101.1-109.5%, respectively. Salicylic acid was measured within nine hours after administration of acetylsalicylic acid tablets. A positive correlation between salicylic acid content in saliva and plasma was found (r = 0.867, p < 0.001). The proposed method was used successfully to measure salicylic acid concentration in human saliva. Meanwhile, we explored the relationship between salicylic acid levels in plasma and saliva. Saliva might replace blood for monitoring aspirin treatment. In addition, the research provides a reference for application to saliva samples.